N

Nathan A. Berger

University School

ORCID: 0000-0001-7086-9885

Publishes on PARP inhibition in cancer therapy, DNA Repair Mechanisms, Cancer therapeutics and mechanisms. 363 papers and 16.6k citations.

PubIndex Score98Top 2%How it's scored

363Publications

16.6kTotal Citations

First publication: 1967First senior author: 1967

PARP inhibition in cancer therapy DNA Repair Mechanisms Cancer therapeutics and mechanisms Cancer Risks and Factors Cancer survivorship and care

Top publicationsby citations

Exercise is the Real Polypill

Carmen Fiuza‐Luces, Alejandro Lucía, Nuria Garatachea et al.|Physiology|2013

Cited by 779

Poly(ADP-Ribose) in the Cellular Response to DNA Damage

Nathan A. Berger|Radiation Research|1985

Cited by 775

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

N K Cheung, Nathan A. Berger, Hillard M. Lazarus et al.|Journal of Clinical Oncology|1987

Cited by 415

Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection

QuanQiu Wang, Rong Xu, Nathan A. Berger|JAMA Oncology|2020

Cited by 402

Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity

Ali Aminian, Steven E. Nissen, Rickesha Wilson et al.|JAMA|2022

Cited by 324